APSR2026-1085

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-070
P125
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245357-46904-APSR2026-1085_439757.pdf
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Philbert John Menia * Amang Rodriguez Memorial Medical Center Section of Pulmonary Medicine Marikina Philippines
Maricon Yap - Amang Rodriguez Memorial Medical Center Section of Pulmonary Medicine Marikina Philippines
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Philbert John
Menia
philbertjohn092987@yahoo.com
+639190092560
31-40
Philippines
Case Report
The Clot and the Koch: The Forgotten Prothrombic State
Maximum 25 words
Abstract Content
 
 
 
 
Tuberculosis is a disease that can affect almost any organ in the body, one of which is vascular complications such as thrombosis. Although unusual, thrombosis may pose challenges in recognition, leading to a significant increase in morbidity and mortality.
A 39-year-old female was admitted due to progressive dyspnea, cough, fever, weight loss and hemoptysis. She is known hypertensive with no recent surgery, unremarkable OB-GYN history with no oral contraceptive use, a 15 pack-year smoker. On PE, she had with severe hypoxemia and respiratory failure. Chest radiograph revealed pleural effusion on the right and CT pulmonary angiography showed right brachiocephalic, subclavian, and axillary vein; pulmonary arteries and biventricular thrombi. There are also mediastinal lymphadenopathies, tree-in-bud pattern in the right upper lobe and right pneumohydrothorax. Initial tests showed leukocytosis, thrombocytosis with unremarkable results of Antinuclear Antibody, C3, Peripheral Blood Smear. Echocardiography showed flail mitral valve. Chest tube thoracostomy was performed and provided respiratory support via HFNC. Anticoagulant and anti-Koch’s medication was given immediately. She was discharged improved.
Tuberculosis itself can induce major hypercoagulable state due to endothelial cell injury through production of cytokines (TNF-α, IL-1β, IL-6), upregulation of tissue factor, platelet activation, NET formation, increase in procoagulant factors and reduced fibrinolytic activity, leading to the appearance of blood clots in veins, lungs, and heart (Mitroi DM, Popa GL, et al. J Clin Med. 2025, 14(3), 762). The hypercoagulable state caused by tuberculosis is characterized by the presence of an active disease, evidence of activation of the coagulation system and exclusion of other etiologies and evidence of clot formation. Treatment consists of a dual strategy, such as therapy against anti-Koch’s and anticoagulants to prevent new clots formation. Prognosis is favorable if there are early detection and treatment (Mitroi DM, Popa GL, et al. J Clin Med. 2025, 14(3), 762).
 
 
Yes
Yes
https://storage.unitedwebnetwork.com/files/1285/1245357-37089-TheClotAndTheKoch1_400639.jpg
JPG or JPEG or PNG format ONLY
Tuberculosis, Thromboembolism, Hypercoagulability
maximum 3 keywords and no abbreviations, separated by commas
 
298